We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 04, 2022

Comparing Antithrombotic Therapies After ACS or PCI in Patients With AF and Prior Stroke

JAMA Cardiology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Cardiology
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
JAMA Cardiol 2022 May 25;[EPub Ahead of Print], MC Bahit, AN Vora, Z Li, DM Wojdyla, L Thomas, SG Goodman, R Aronson, JD Jordan, BJ Kolls, KE Dombrowski, D Vinereanu, S Halvorsen, O Berwanger, S Windecker, R Mehran, CB Granger, JH Alexander, RD Lopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading